Home Liver News NGM Names Castlight’s Nolan Mangini as Its Chief Financial Officer

NGM Names Castlight’s Nolan Mangini as Its Chief Financial Officer

Credits to the Source Link Daniel
Sarah de Crescenzo

Xconomy
San Francisco
— 

NGM Biopharmaceuticals (NASDAQ: NGM) added Siobhan Nolan Mangini to its C-suite as chief financial officer. Nolan Mangini, formerly president and CFO of Castlight Health (NYSE: CSLT), starts the new role at South San Francisco-based NGM on July 13. Prior to Castlight, Nolan Mangini’s experience includes time as a management consultant at Bain & Company and a financial associate at the Henry J. Kaiser Family Foundation.

NGM’s lead drug candidate, an engineered variant of the human hormone fibroblast growth factor 19, is in mid-stage testing as a once-daily injection for the treatment of nonalcoholic fatty liver disease (NASH).

Sarah de Crescenzo is an Xconomy editor based in San Diego. You can reach her at sdecrescenzo@xconomy.com. Follow @sarahdc

Trending on Xconomy



Source Link

Related Articles

Leave a Comment

This website uses cookies to improve your experience. We will assume you are ok with this, but you can opt-out if you wish. Accept Read More